Inspire Investing LLC Purchases Shares of 44,585 Teladoc Health, Inc. (NYSE:TDOC)

Inspire Investing LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 44,585 shares of the health services provider’s stock, valued at approximately $409,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Signaturefd LLC raised its position in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC acquired a new position in shares of Teladoc Health in the 2nd quarter worth approximately $29,000. SageView Advisory Group LLC bought a new position in shares of Teladoc Health during the 1st quarter worth approximately $48,000. Covestor Ltd boosted its stake in Teladoc Health by 58.1% in the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock valued at $57,000 after buying an additional 1,403 shares in the last quarter. Finally, Doheny Asset Management CA bought a new stake in Teladoc Health in the second quarter valued at $46,000. 76.82% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the sale, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CEO Laizer Kornwasser sold 10,879 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the completion of the transaction, the chief executive officer now directly owns 99,929 shares in the company, valued at approximately $813,422.06. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 57,377 shares of company stock valued at $438,054 in the last 90 days. 0.95% of the stock is owned by insiders.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $9.83 on Friday. The firm has a fifty day moving average of $8.12 and a two-hundred day moving average of $10.07. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. The stock has a market capitalization of $1.67 billion, a price-to-earnings ratio of -6.97 and a beta of 0.91. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $22.54.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.08. The firm had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. As a group, equities research analysts predict that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Analysts Set New Price Targets

TDOC has been the topic of several recent analyst reports. Evercore ISI boosted their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Truist Financial reduced their price target on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research report on Friday, August 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $10.00 price objective on shares of Teladoc Health in a report on Tuesday, August 20th. JPMorgan Chase & Co. reduced their target price on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a report on Monday, August 26th. Finally, DA Davidson dropped their price target on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a report on Thursday, August 1st. Fifteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.81.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.